These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 9792263)

  • 1. Inverse relationship between aldosterone and large artery compliance in chronically treated heart failure patients.
    Duprez DA; De Buyzere ML; Rietzschel ER; Taes Y; Clement DL; Morgan D; Cohn JN
    Eur Heart J; 1998 Sep; 19(9):1371-6. PubMed ID: 9792263
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inverse relation between aldosterone and venous capacitance in chronically treated congestive heart failure.
    Rietzschel E; Duprez DA; De Buyzere ML; Clement DL
    Am J Cardiol; 2000 Apr; 85(8):977-80. PubMed ID: 10760338
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aldosterone and artery compliance in heart failure.
    Struthers A
    Eur Heart J; 1998 Sep; 19(9):1273. PubMed ID: 9792248
    [No Abstract]   [Full Text] [Related]  

  • 4. Relation of aldosterone "escape" despite angiotensin-converting enzyme inhibitor administration to impaired exercise capacity in chronic congestive heart failure secondary to ischemic or idiopathic dilated cardiomyopathy.
    Cicoira M; Zanolla L; Franceschini L; Rossi A; Golia G; Zeni P; Caruso B; Zardini P
    Am J Cardiol; 2002 Feb; 89(4):403-7. PubMed ID: 11835920
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neurohormonal effects of furosemide withdrawal in elderly heart failure patients with normal systolic function.
    van Kraaij DJ; Jansen RW; Sweep FC; Hoefnagels WH
    Eur J Heart Fail; 2003 Jan; 5(1):47-53. PubMed ID: 12559215
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acute vascular effects of the angiotensin II receptor antagonist olmesartan in normal subjects: relation to the renin-aldosterone system.
    Resnick LM; Catanzaro D; Sealey JE; Laragh JH
    Am J Hypertens; 2004 Mar; 17(3):203-8. PubMed ID: 15001191
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Determinants of increased angiotensin II levels in severe chronic heart failure patients despite ACE inhibition.
    van de Wal RM; Plokker HW; Lok DJ; Boomsma F; van der Horst FA; van Veldhuisen DJ; van Gilst WH; Voors AA
    Int J Cardiol; 2006 Jan; 106(3):367-72. PubMed ID: 16337046
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of angiotensin-converting enzyme inhibitors in congestive heart failure.
    Galvao M
    Heart Lung; 1990 Sep; 19(5 Pt 1):505-11. PubMed ID: 2211159
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acute hemodynamic effects of drugs acting on the renin-angiotensin system in acute heart failure.
    Nekooeian AA; Ogilvie RI; Zborowska-Sluis D
    Can J Cardiol; 1995 Jan; 11(1):59-64. PubMed ID: 7850666
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Urocortin 2 combined with angiotensin-converting enzyme inhibition in experimental heart failure.
    Rademaker MT; Charles CJ; Nicholls MG; Richards AM
    Clin Sci (Lond); 2008 May; 114(10):635-42. PubMed ID: 18052934
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of drugs on a noninvasive index of arterial compliance in healthy and heart failure patients.
    Domingo E; Gilabert MR; Alio J; Angel J; Soler-Soler J
    Cathet Cardiovasc Diagn; 1991 Oct; 24(2):93-8. PubMed ID: 1742791
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [ACE inhibition: mechanisms of cardioprotection in chronic experimental heart failure].
    Riegger AJ
    Klin Wochenschr; 1991; 69 Suppl 24():20-3. PubMed ID: 1830909
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Is there a role for renin profiling in selecting chronic heart failure patients for ACE inhibitor treatment?
    Lim PO; MacFadyen RJ; Struthers AD
    Heart; 2000 Mar; 83(3):257-61. PubMed ID: 10677399
    [TBL] [Abstract][Full Text] [Related]  

  • 14. How often are angiotensin II and aldosterone concentrations raised during chronic ACE inhibitor treatment in cardiac failure?
    MacFadyen RJ; Lee AF; Morton JJ; Pringle SD; Struthers AD
    Heart; 1999 Jul; 82(1):57-61. PubMed ID: 10377310
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Does captopril decrease endothelial production of endothelin?].
    Mazurek W; Halawa B
    Pol Merkur Lekarski; 1997 Sep; 3(15):105-8. PubMed ID: 9461703
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Angiotensin II contributes to arterial compliance in congestive heart failure.
    Lage SG; Kopel L; Medeiros CC; Carvalho RT; Creager MA
    Am J Physiol Heart Circ Physiol; 2002 Oct; 283(4):H1424-9. PubMed ID: 12234793
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Angiotensin-converting enzyme inhibition and radial artery compliance in patients with congestive heart failure.
    Giannattasio C; Failla M; Stella ML; Mangoni AA; Turrini D; Carugo S; Pozzi M; Grassi G; Mancia G
    Hypertension; 1995 Sep; 26(3):491-6. PubMed ID: 7649587
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Myogenic constriction is increased in mesenteric resistance arteries from rats with chronic heart failure: instantaneous counteraction by acute AT1 receptor blockade.
    Gschwend S; Henning RH; Pinto YM; de Zeeuw D; van Gilst WH; Buikema H
    Br J Pharmacol; 2003 Aug; 139(7):1317-25. PubMed ID: 12890711
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neurohormonal activation in patients with acute myocardial infarction or chronic congestive heart failure. With special reference to treatment with angiotensin converting enzyme inhibitors.
    Sigurdsson A
    Blood Press Suppl; 1995; 1():1-45. PubMed ID: 7599749
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aldosterone in congestive heart failure.
    Weber KT
    N Engl J Med; 2001 Dec; 345(23):1689-97. PubMed ID: 11759649
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.